Tocilizumab - CAS 375823-41-9

Tocilizumab (Anti-Human IL6R) is a neutralizing antibody against human interleukin-6 receptor (IL-6R) that blocks the binding of IL-6 to IL-6R, thereby inhibiting both classical and trans signaling. It can be used to study rheumatoid arthritis and has been suggested as a possible drug for the treatment of severe COVID-19.

Interleukin

Immunology/Inflammation

375773

0.995

-20°C

Ice Packs

Inhibitory Antibodies